Literature DB >> 19131675

Evaluating the cancer detection and grading potential of prostatic-zinc imaging: a simulation study.

M Cortesi1, R Chechik, A Breskin, D Vartsky, J Ramon, G Raviv, A Volkov, E Fridman.   

Abstract

The present work deals with the analysis of prostatic-zinc-concentration images. The goal is to evaluate potential clinically relevant information that can be extracted from such images. In the absence of experimental images, synthetic ones are produced from clinically measured zinc-concentration distributions in certified benign and cancerous tissue samples, classified by the lesion grade. We describe the method for producing the images and model the effect of counting statistics noise. We present in detail the image analysis, which is based on a combination of standard image processing and segmentation tools, optimized for this particular application. The information on lowest zinc value obtained from the image analysis is translated to clinical data such as tumour presence, location, size and grade. Their confidence is evaluated with the help of standard statistical tools such as receiver operating characteristic analysis. The present work predicts a potential for detecting small prostate-cancer lesions, of grade (4+3) and above, with very good specificity and sensitivity. The present analysis further provides data on the pixel size and image counting statistics requested from the trans-rectal probe that will record in vivo prostatic-zinc maps in patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131675     DOI: 10.1088/0031-9155/54/3/020

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

1.  Zinc as an Imaging Biomarker of Prostate Cancer.

Authors:  Su-Tang Lo; André F Martins; Veronica Clavijo Jordan; A Dean Sherry
Journal:  Isr J Chem       Date:  2017-07-31       Impact factor: 3.333

2.  A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing.

Authors:  Subrata K Ghosh; Pilhan Kim; Xiao-an Zhang; Seok-Hyun Yun; Anna Moore; Stephen J Lippard; Zdravka Medarova
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

Review 3.  Zinc is decreased in prostate cancer: an established relationship of prostate cancer!

Authors:  Leslie C Costello; Renty B Franklin
Journal:  J Biol Inorg Chem       Date:  2010-12-08       Impact factor: 3.358

Review 4.  Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer.

Authors:  Yue Yuan; Zhiliang Wei; Chengyan Chu; Jia Zhang; Xiaolei Song; Piotr Walczak; Jeff W M Bulte
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-17       Impact factor: 15.336

5.  Risk stratification of prostate cancer patients based on EPS-urine zinc content.

Authors:  Zdravka Medarova; Subrata K Ghosh; Mark Vangel; Richard Drake; Anna Moore
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

Review 6.  Advances of Zinc Signaling Studies in Prostate Cancer.

Authors:  Dangdang Li; Daniel B Stovall; Wenmeng Wang; Guangchao Sui
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.